197 related articles for article (PubMed ID: 3555581)
21. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
22. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
[TBL] [Abstract][Full Text] [Related]
23. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
[TBL] [Abstract][Full Text] [Related]
24. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
25. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
[TBL] [Abstract][Full Text] [Related]
26. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
[TBL] [Abstract][Full Text] [Related]
27. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
Brockelman CR; Thanomsub B; Bhisutthibhand J
Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Burchard GD; Winkler E
Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H
Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309
[No Abstract] [Full Text] [Related]
30. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Arnold K
Lancet; 1985 Mar; 1(8430):704. PubMed ID: 2858655
[No Abstract] [Full Text] [Related]
31. Efficacies of chloroquine and pyrimethamine-sulphadoxine in a Nigerian population with chloroquine resistant P. falciparum malaria.
Usanga EA; Ezedinachi EN; Gemade EI; Ikpatt NW; Alaribe AA
East Afr Med J; 1990 May; 67(5):295-301. PubMed ID: 2202586
[TBL] [Abstract][Full Text] [Related]
32. Chloroquine-resistant falciparum malaria from East Africa.
Bhattacharya DN; Hall AP
J Trop Med Hyg; 1986 Dec; 89(6):291-4. PubMed ID: 3543385
[TBL] [Abstract][Full Text] [Related]
33. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.
Meek SR; Doberstyn EB; Gaüzère BA; Thanapanich C; Nordlander E; Phuphaisan S
Am J Trop Med Hyg; 1986 Mar; 35(2):246-50. PubMed ID: 3513642
[TBL] [Abstract][Full Text] [Related]
34. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
Kilimali VA; Mkufya AR
Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
[TBL] [Abstract][Full Text] [Related]
35. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Li GQ; Arnold K; Guo XB; Jian HX; Fu LC
Lancet; 1984 Dec; 2(8416):1360-1. PubMed ID: 6150365
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine.
Ponnampalam JT
J Trop Med Hyg; 1978 Oct; 81(10):198-203. PubMed ID: 366165
[No Abstract] [Full Text] [Related]
37. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
38. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
Vleugels MP; Wetsteyn JC; Meuwissen JH
Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
[TBL] [Abstract][Full Text] [Related]
39. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
Olatunde A; Salako LA; Walker O
Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
[TBL] [Abstract][Full Text] [Related]
40. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
